Antioxidant status of serum bilirubin and uric acid in patients with polymyositis and dermatomyositis

References

• Wang Y, Hekimi S. Mitochondrial dysfunction and longevity in animals: untangling the knot. Science (New York, NY) 2015;350:1204–7.
   Google Scholar
• Harrison IP, Selemidis S. Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets. Clin Exp Pharmacol Physiol 2014;41:533–42.
   PubMed Web of Science ®Google Scholar
• Ogura J, Kuwayama K, Sasaki S, et al. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen. Biochem Pharmacol 2015;97:89–98.
   PubMed Web of Science ®Google Scholar
• Pauwels EK, Erba PA, Kostkiewicz M. Antioxidants: a tale of two stories. Drug News Perspect 2007;20:579–85.
   PubMedGoogle Scholar
• Zhou ZX, Chen JK, Hong YY, et al. Relationship between the serum total bilirubin and inflammation in patients with psoriasis vulgaris. J Clin Lab Anal 2016. doi:10.1002/jcla.21936 [Epub ahead of print].
   Web of Science ®Google Scholar
• Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science (New York, NY) 1987;235:1043–6.
   Google Scholar
• Takeda TA, Mu A, Tai TT, et al. Continuous de novo biosynthesis of haem and its rapid turnover to bilirubin are necessary for cytoprotection against cell damage. Sci Rep 2015;5:10488. doi:10.1038/srep10488 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Gong L, Zhang QL, Zhang N, et al. Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3beta signaling pathway. J Neurochem 2012;123:876–85.
   PubMed Web of Science ®Google Scholar
• Brambilla D, Mancuso C, Scuderi MR, et al. The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile. Nutr J 2008;7:29. doi:10.1186/1475-2891-7-29 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Wang P, Xie K, Wang C, et al. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis. Eur Neurol 2014;72:249–54.
   PubMed Web of Science ®Google Scholar
• Penton-Rol G, Cervantes-Llanos M, Martinez-Sanchez G, et al. TNF-alpha and IL-10 downregulation and marked oxidative stress in neuromyelitis optica. J Inflam (London, England) 2009;6:18. doi:10.1186/1476-9255-6-18 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Stuerenburg HJ. The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases. Biochem Biokhim 2000;65:862–5.
   PubMed Web of Science ®Google Scholar
• Neha, AMM, Khan HA. Yohimbine hydrochloride ameliorates collagen type-II-induced arthritis targeting oxidative stress and inflammatory cytokines in Wistar rats. Environ Toxicol 2016. doi:10.1002/tox.22264 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Lopez-Pedrera C, Barbarroja N, Jimenez-Gomez Y, et al. Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches. Rheumatology (Oxford) 2016. doi:10.1093/rheumatology/kew054 [Epub ahead of print].
   Web of Science ®Google Scholar
• Powers SK, Ji LL, Kavazis AN, et al. Reactive oxygen species: impact on skeletal muscle. Compr Physiol 2011;1:941–69.
   PubMed Web of Science ®Google Scholar
• Lightfoot AP, McArdle A, Jackson MJ, et al. In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness? Ann Rheum Dis 2015;74:1340–6.
   PubMed Web of Science ®Google Scholar
• Tews DS, Goebel HH. Cell death and oxidative damage in inflammatory myopathies. Clin Immunol Immunopathol 1998;87:240–7.
   PubMedGoogle Scholar
• Yang D, Su Z, Wu S, et al. Low antioxidant status of serum bilirubin, uric acid, albumin and creatinine in patients with myasthenia gravis. Int J Neurosci 2016:1–7. doi:10.3109/00207454.2015.1134526 [Epub ahead of print].
   Web of Science ®Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–7.
   PubMed Web of Science ®Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–7.
   PubMed Web of Science ®Google Scholar
• Peng YF, Zhang L, Pan GG, et al. A potential clinical usefulness of measuring serum bilirubin levels in patients with polymyositis. Eur Rev Med Pharmacol Sci 2016;20:631–5.
   PubMed Web of Science ®Google Scholar
• Peng F, Zhang B, Zhong X, et al. Serum uric acid levels of patients with multiple sclerosis and other neurological diseases. Mult Scler 2008;14:188–96.
   PubMed Web of Science ®Google Scholar
• Stangel M, Mix E, Zettl UK, et al. Oxides and apoptosis in inflammatory myopathies. Microsc Res Tech 2001;55:249–58.
   PubMed Web of Science ®Google Scholar
• Lightfoot AP, Nagaraju K, McArdle A, et al. Understanding the origin of non-immune cell-mediated weakness in the idiopathic inflammatory myopathies - potential role of ER stress pathways. Curr Opin Rheumatol 2015;27:580–5.
   PubMed Web of Science ®Google Scholar
• Kushida T, LiVolti G, Goodman AI, et al. TNF-alpha-mediated cell death is attenuated by retrovirus delivery of human heme oxygenase-1 gene into human microvessel endothelial cells. Transplant Proc 2002;34:2973–8.
   PubMed Web of Science ®Google Scholar
• Peng F, Deng X, Yu Y, et al. Serum bilirubin concentrations and multiple sclerosis. J Clin Neurosci 2011;18:1355–9.
   PubMed Web of Science ®Google Scholar
• Fuhua P, Xuhui D, Zhiyang Z, et al. Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis. NeuroImmunoModulation 2012;19:43–9.
   PubMed Web of Science ®Google Scholar
• Kim ES, Lee SW, Mo EY, et al. Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes. Endocrine 2015;50:405–12.
   PubMed Web of Science ®Google Scholar
• Nishimura T, Tanaka M, Sekioka R, et al. Serum bilirubin concentration is associated with eGFR and urinary albumin excretion in patients with type 1 diabetes mellitus. J Diabetes Complications 2015;29:1223–7.
   PubMed Web of Science ®Google Scholar
• Patel JJ, Taneja A, Niccum D, et al. The association of serum bilirubin levels on the outcomes of severe sepsis. J Intensive Care Med 2015;30:23–9.
   PubMed Web of Science ®Google Scholar
• Moccia M, Lanzillo R, Palladino R, et al. Uric acid: a potential biomarker of multiple sclerosis and of its disability. Clin Chem Lab Med 2015;53:753–9.
   PubMed Web of Science ®Google Scholar
• Min JH, Waters P, Vincent A, et al. Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO. Acta Neurol Scand 2012;126:287–91.
   PubMed Web of Science ®Google Scholar
• Yang D, Weng Y, Lin H, et al. Serum uric acid levels in patients with myasthenia gravis are inversely correlated with disability. Neuroreport 2016;27:301–5.
   PubMed Web of Science ®Google Scholar
• Hooper DC, Scott GS, Zborek A, et al. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 2000;14:691–8.
   PubMed Web of Science ®Google Scholar
• Markowitz CE, Spitsin S, Zimmerman V, et al. The treatment of multiple sclerosis with inosine. J Altern Complement Med 2009;15:619–25.
   PubMed Web of Science ®Google Scholar